Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of SIMVASTATIN to Treat Chronic Rhinosinusitis After Failure of Optimal Treatment

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women aged between 18 and 65 years.~* Chronic rhinosinusitis with or without nasal polyposis requiring functional endoscopic surgery type of bilateral total ethmoidectomy older than six months~* Failure (clinical and endoscopic score \> 1 on a scale of 3) of conventional treatment after surgery followed by local treatment with corticosteroids and saline irrigation)~Exclusion Criteria:~* Cystic Fibrosis~* Primary immunodeficiencies or documented acquired~* Diabetes~* Taking anticoagulants or bleeding disorders~* Taking oral cortisone within 30 days prior to the inclusion~* Taking antibiotics within 30 days prior to the inclusion~* Sinus or nasal surgery in past six months~* Contraindication to statins (pregnancy or lactating; people consuming high quantities of alcohol (3 drinks/day or more), liver disease, severe renal failure, myopathy, hypersensitivity to statins, abnormally elevated transaminase coagulation)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- SIMVASTATIN 40mg (Type: EXPERIMENTAL): SIMVASTATIN tablet of 40mg once a day during 30 days. Single arm with pre and post treament assessment

Based on this trial design, predict the completion outcome and termination type (if applicable).